Bellerophon Therapeutics, Inc. Gains 42.39%

Mon, Jun 27, 2022 at 08:30 PM
Bellerophon Therapeutics, Inc. Gains 42.39%

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) soared at $1.31, a gain of 42.4%. On Mon, Jun 27, 2022, BLPH:NASDAQ hit a New 2-Week High of $1.31. From Mon, Jun 13, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days

About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.